Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,276 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neutralization of SARS-CoV-2 Omicron subvariant BA.2.87.1.
Lasrado N, Rössler A, Rowe M, Collier AY, Barouch DH. Lasrado N, et al. Among authors: rowe m. Vaccine. 2024 Apr 2;42(9):2117-2121. doi: 10.1016/j.vaccine.2024.03.007. Epub 2024 Mar 7. Vaccine. 2024. PMID: 38458874 Free article.
Comparable Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants.
Yu J, Collier AY, Rowe M, Mardas F, Ventura JD, Wan H, Miller J, Powers O, Chung B, Siamatu M, Hachmann NP, Surve N, Nampanya F, Chandrashekar A, Barouch DH. Yu J, et al. Among authors: rowe m. medRxiv [Preprint]. 2022 Feb 7:2022.02.06.22270533. doi: 10.1101/2022.02.06.22270533. medRxiv. 2022. PMID: 35169817 Free PMC article. Updated. Preprint.
Neutralization escape by SARS-CoV-2 Omicron subvariant BA.2.86.
Lasrado N, Collier AY, Hachmann NP, Miller J, Rowe M, Schonberg ED, Rodrigues SL, LaPiana A, Patio RC, Anand T, Fisher J, Mazurek CR, Guan R, Wagh K, Theiler J, Korber BT, Barouch DH. Lasrado N, et al. Among authors: rowe m. Vaccine. 2023 Nov 13;41(47):6904-6909. doi: 10.1016/j.vaccine.2023.10.051. Epub 2023 Oct 21. Vaccine. 2023. PMID: 37872011 Free article.
Characterization of immune responses in fully vaccinated individuals after breakthrough infection with the SARS-CoV-2 delta variant.
Collier AY, Brown CM, McMahan KA, Yu J, Liu J, Jacob-Dolan C, Chandrashekar A, Tierney D, Ansel JL, Rowe M, Sellers D, Ahmad K, Aguayo R, Anioke T, Gardner S, Siamatu M, Bermudez-Rivera L, Hacker MR, Madoff LC, Barouch DH. Collier AY, et al. Among authors: rowe m. Sci Transl Med. 2022 Apr 20;14(641):eabn6150. doi: 10.1126/scitranslmed.abn6150. Epub 2022 Apr 20. Sci Transl Med. 2022. PMID: 35258323 Free PMC article.
Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants.
Yu J, Collier AY, Rowe M, Mardas F, Ventura JD, Wan H, Miller J, Powers O, Chung B, Siamatu M, Hachmann NP, Surve N, Nampanya F, Chandrashekar A, Barouch DH. Yu J, et al. Among authors: rowe m. N Engl J Med. 2022 Apr 21;386(16):1579-1580. doi: 10.1056/NEJMc2201849. Epub 2022 Mar 16. N Engl J Med. 2022. PMID: 35294809 Free PMC article. No abstract available.
Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5.
Hachmann NP, Miller J, Collier AY, Ventura JD, Yu J, Rowe M, Bondzie EA, Powers O, Surve N, Hall K, Barouch DH. Hachmann NP, et al. Among authors: rowe m. N Engl J Med. 2022 Jul 7;387(1):86-88. doi: 10.1056/NEJMc2206576. Epub 2022 Jun 22. N Engl J Med. 2022. PMID: 35731894 Free PMC article. No abstract available.
Durability of Heterologous and Homologous COVID-19 Vaccine Boosts.
Tan CS, Collier AY, Yu J, Liu J, Chandrashekar A, McMahan K, Jacob-Dolan C, He X, Roy V, Hauser BM, Munt JE, Mallory ML, Mattocks M, Powers JM, Meganck RM, Rowe M, Hemond R, Bondzie EA, Jaegle KH, Baric RS, Schmidt AG, Alter G, Le Gars M, Sadoff J, Barouch DH. Tan CS, et al. Among authors: rowe m. JAMA Netw Open. 2022 Aug 1;5(8):e2226335. doi: 10.1001/jamanetworkopen.2022.26335. JAMA Netw Open. 2022. PMID: 35947380 Free PMC article.
Immunogenicity of the BA.5 Bivalent mRNA Vaccine Boosters.
Collier AY, Miller J, Hachmann NP, McMahan K, Liu J, Apraku Bondzie E, Gallup L, Rowe M, Schonberg E, Thai S, Barrett J, Borducchi EN, Bouffard E, Jacob-Dolan C, Mazurek CR, Mutoni A, Powers O, Sciacca M, Surve N, VanWyk H, Wu C, Barouch DH. Collier AY, et al. Among authors: rowe m. bioRxiv [Preprint]. 2022 Oct 25:2022.10.24.513619. doi: 10.1101/2022.10.24.513619. bioRxiv. 2022. PMID: 36324798 Free PMC article. Updated. Preprint.
Immunogenicity of BA.5 Bivalent mRNA Vaccine Boosters.
Collier AY, Miller J, Hachmann NP, McMahan K, Liu J, Bondzie EA, Gallup L, Rowe M, Schonberg E, Thai S, Barrett J, Borducchi EN, Bouffard E, Jacob-Dolan C, Mazurek CR, Mutoni A, Powers O, Sciacca M, Surve N, VanWyk H, Wu C, Barouch DH. Collier AY, et al. Among authors: rowe m. N Engl J Med. 2023 Feb 9;388(6):565-567. doi: 10.1056/NEJMc2213948. Epub 2023 Jan 11. N Engl J Med. 2023. PMID: 36630611 Free PMC article. No abstract available.
Waning Immunity Against XBB.1.5 Following Bivalent mRNA Boosters.
Lasrado N, Collier AY, Miller J, Hachmann NP, Liu J, Sciacca M, Wu C, Anand T, Bondzie EA, Fisher JL, Mazurek CR, Patio RC, Powers O, Rodrigues SL, Rowe M, Surve N, Ty DM, Korber B, Barouch DH. Lasrado N, et al. Among authors: rowe m. bioRxiv [Preprint]. 2023 Jan 23:2023.01.22.525079. doi: 10.1101/2023.01.22.525079. bioRxiv. 2023. PMID: 36747640 Free PMC article. Preprint.
1,276 results